Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension

European Respiratory Journal

Volumn 46, Issue 2, 2015, Pages 422-430

  Jacobs, Wouter ^a,b   Konings, Thelma C ^a   Heymans, Martijn W ^a   Boonstra, Anco ^a   Bogaard, Harm Jan ^a   Van Rossum, Albert C ^a   Vonk Noordegraaf, Anton ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM ENLARGEMENT; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VALVULAR HEART DISEASE; BIOLOGICAL MODEL; COMPLICATION; ELECTROCARDIOGRAPHY; HEART FAILURE; HYPERTENSION, PULMONARY; MIDDLE AGED; NETHERLANDS; PROGNOSIS; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NETHERLANDS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84938860482     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00202814     Document Type: Article

References (40)

1. Simonneau G, Galiè N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 1S-12S.
2. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-349.
3. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary arterial hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
4. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: Suppl. 1, S55-S66.
5. Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med 2007; 28: 233-241.
6. Hoeper MM, Barbera JA, Channick RN, et al. Diagnosis, assessment and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl. 1, S85-S96.
7. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.
8. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterisation procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006; 48: 2546-2552.
9. Kannel WB, D'Agustino RB, Silbershatz H, et al. Profile for estimating risk of heart failure. Arch Intern Med 1999; 159: 1197-1204.
10. He J, Ogden LG, Bazzamo LA, et al. Risk factors for congestive heart failure in US men and women. NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161: 996-1002.
11. Leung DY, Boyd A, Ng AA, et al. Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. Am Heart J 2008; 156: 1056-1064.
12. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
13. Fox KF, Cowie MR, Wood DA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001; 22: 228-236.
14. McLaughlin VV, Badesch DB, Barst RJ, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573-1619.
15. Robbins IM, Hemnes AR, Pugh ME, et al. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 2014; 7: 116-122.
16. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
17. Lancellotti P, Moura L, Pierard LA, et al. European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: 307-332.
18. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009; 10: 1-25.
19. Lancellotti P, Tribouilloy C, Hagendorff A, et al. European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: 223-244.
20. Wood AM, White IR, Royston P. How should variable selection be performed with multiply imputed data? Stat Med 2008; 27: 3227-3246.
21. Harrel FE. Regression Modeling Strategies. Berlin, Springer, 2001.
22. R Development Core Team 2010. R: a Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2010.
23. Shapiro BP, Nishimura RA, McGoon MD, et al. Diagnostic dilemmas: diastolic heart failure causing pulmonary hypertension and pulmonary hypertension causing diastolic dysfunction. Adv Pulm Hypertens 2006; 5: 13-20.
24. Thenappan T, Shah S, Gomberg-Maitland M, et al. Clinical characteristic of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2011; 4: 257-265.
25. Galiè N, Rubin LJ, Hoeper MM, et al. Treatment of patients with mildly progressive pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 2008; 371: 2093-2100.
26. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-302.
27. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam study. Eur Heart J 2004; 25: 1614-1619.
28. Gabbay E, Yeow W, Playford D, et al. Pulmonary arterial hypertension (PAH) is an uncommon cause of pulmonary hypertension (PH) in an unselected population: the Armadale echocardiography study. Am J Respir Crit Care Med 2007; 175: A713.
29. Hardziyenka M, Campian ME, Reesink HJ, et al. Right ventricular failure following chronic pressure overload is associated with reduction in left ventricular mass: evidence for atrophic remodeling. J Am Coll Cardiol 2011; 57: 921-928.
30. Crawley SF, Johnson MK, Dargie HJ, et al. LA volume by CMR distinguishes idiopathic from pulmonary hypertension due to HFpEF. JACC Cardiovasc Imaging 2013; 6: 1120-1121.
31. Whitlock M, Garg A, Gelow J, et al. Comparison of left and right atrial volume by echocardiography versus cardiac magnetic resonance imaging using the area-length method. Am J Cardiol 2010; 106: 1345-1350.
32. Brittain EL, Pugh ME, Wang L, et al. Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension. PLoS One 2013; 8: e76461.
33. Waggoner AD, Adyanthaya AV, Quinones MA, et al. Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria. Circulation 1976; 54: 553-557.
34. Lee KS, Appleton CP, Lester SJ, et al. Relation of electrocardiographic criteria for left atrial enlargement to two-dimensional echocardiographic left atrial volume measurements. Am J Cardiol 2007; 99: 113-118.
35. Bonderman D, Wexberg P, Martischnig AM, et al. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J 2011; 37: 1096-1103.
36. Austin PC. A comparison of regression trees, logistic regression, generalized additive models, amd multivariate adaptive regression splines for predicting AMI mortality. Stat Med 2007; 26: 2937-2957.
37. Frost AE, Farber HW, Barst RJ, et al. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18mmHg: insights from the REVEAL Registry. Chest 2013; 143: 185-195.
38. Borlaug BA, Nishimura RA, Sorajja P, et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010; 3: 588-595.
39. Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284-1289.
40. Arkles JS, Opotowsky AR, Ojeda J, et al. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am J Respir Crit Care Med 2011; 183: 268-276.